This document provides an overview of the key departments and functions within the pharmaceutical industry. It describes the roles of production, quality control, quality assurance, engineering, regulatory affairs, and clinical research organizations. It also outlines the responsibilities of key personnel like heads of production and quality control, as well as the qualified person. The document emphasizes that effective quality management systems are important for product realization, process control, and continual improvement.
Pharmaceutical Industry Departments roles and responsibilities manasa life sc...ManasaLifeSciencesMa
Pharmaceutical Industry Departments and its roles and responsibilities were discussed. Product selection, Development, Manufacturing, Product approval, Marketing
Good Manufacturing Practice is a set of regulations, codes, and guidelines for the manufacture of drug substances and drug products, medical devices, in vivo and in vitro diagnostic products, and foods.
Pharmaceutical Industry Departments roles and responsibilities manasa life sc...ManasaLifeSciencesMa
Pharmaceutical Industry Departments and its roles and responsibilities were discussed. Product selection, Development, Manufacturing, Product approval, Marketing
Good Manufacturing Practice is a set of regulations, codes, and guidelines for the manufacture of drug substances and drug products, medical devices, in vivo and in vitro diagnostic products, and foods.
“A GMP is a system for ensuring that products are consistently produced and controlled according to quality standards. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product”.
The India Pharmaceutical Industry is developing, producing and marketing drugs.
The pharmaceutical companies are generally dealing in generic or brand medications and medical device.
Indian Pharmaceutical Industry today is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology.
India enjoys a important position in the global pharmaceutical market. The Indian pharmaceuticals market is the third largest in terms of volume and thirteenth largest in terms of value.
It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured.
complete description about pharmaceutical industry how it work how it is operated both at micro as well as macro level. it also include leading pharma firms in market. in simple words if we say it is an industry analysis.
Regulatory affairs in Pharmaceutical IndustryRama Shukla
Regulatory affairs is a profession developed from the desire of governments to protect public health by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines.
Good Manufacturing Practice (GMP) is a system for ensuring that products are consistently produced and controlled according to quality standards. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product.
Pharmaceutical, Bulk Drugs and Medicine Manufacturing Industry (Production, F...Ajjay Kumar Gupta
Quality control and quality assurance are vital in this industry. Many production workers are assigned full time to quality control and quality assurance functions, whereas other employees may devote part of their time to these functions. For example, although pharmaceutical company sales representatives, often called detailers, work primarily in marketing, they engage in quality control when they assist pharmacists in checking for outdated products.
Advances in manufacturing processes are also impacting the industry. While pharmaceutical manufacturers have long devoted resources to new drug development as a source for future profits, firms are increasingly realizing that improvements throughout the drug pipeline are needed to stay competitive.
See more
http://goo.gl/1sQLwS
http://goo.gl/jajeNa
http://goo.gl/0tvlst
http://www.entrepreneurindia.co/
Tags
Pharmaceutical Technology Books, Essentials of Pharmaceutical Technology, Pharmaceutical Technology, Pharmaceutical books, Science, Technology & Medicine Books, Drugs technology books, Drug and Pharmaceuticals technology book, Best small and cottage scale industries, Bulk Drugs Formulation, Bulk Drugs Manufacturing Industry, Business consultancy, Business consultant, Business guidance for Pharmaceutical industry, Business guidance to clients, Business Plan for a Startup Business, Creating a Pharma Start-up, Drug formulation manual, Formulation of Antibiotics, Formulation of Paracetamol, Formulation of Tablets, Great Opportunity for Startup, How to Start a Medicines manufacturing business?, How to start a pharmaceutical company, How to Start a Pharmaceutical Product Business, How to Start a Pharmaceutical Production Business, How to start a pharmacy business, How to start a successful drugs making business, How to start Antibiotics manufacturing business, How to start drugs pharmaceutical business, How to start medicine business, How to Start Medicine Manufacturing Industry in India, How to start medicine manufacturing, How to start Paracetamol production business, How to Start Pharmaceutical Manufacturing Company in India, Invest to setup a pharmaceutical business, Manufacturing of medicinal products- Pharmaceutical industry, Medicine Manufacturing Industry, Medicines Making Small Business Manufacturing, Modern small and cottage scale industries, Most Profitable Bulk Drugs production Business Ideas, New small scale ideas in Pharmaceutical industry, Pharma Manufacturing, Pharmaceutical and Medicines production Business, Pharmaceutical Based Profitable Projects, Pharmaceutical Based Small Scale Industries Projects, Pharmaceutical Drug Formulation, Pharmaceutical Drug Manufacturing Business, Pharmaceutical formulation guidelines, Pharmaceutical formulation, Pharmaceutical industry in India, Pharmaceutical industry, Pharmaceutical manufacturing Industry in India, Pharmaceutical Manufacturing Industry, Pharmaceutical Projects,
Quality control measures in pharmaceutical industryChemOnTheGo
QUALITY CONTROL
ROLE OF QUALITY CONTROL IN PHARMACEUTICAL INDUSTRY
OBJECTIVES OF QUALITY CONTROL
STEPS IN QUALITY CONTROL
COST OF QUALITY CONTROL
TOTAL QUALITY MANAGEMENT
QUALITY CIRCLE
Regulatory authorities (US-FDA, WHO and ICH)Sagar Savale
To promote the public health by promptly and efficiently reviewing clinical research and taking appropriate action on the marketing of regulated products in a timely manner.
With respect to such products, protect the public health by ensuring that the food are safe, Wholesome, sanitary, and properly labelled; human and veterinary drugs are safe and effective; there is reasonable assurance of the safety and effectiveness of devices intended for human use; cosmetics are safe and properly labelled, and public health and safety are protected from the electronic product radiation.
Participates through appropriate process with representatives of other countries to reduce the burden of regulation, harmonize regulatory requirements, and achieve appropriate reciprocal arrangements.
DRA (Drug Regulatory Affairs) , RA (Regulatory Affairs)Naman Ruhela
A Brief Introduction about the Regulatory Affairs / Drug Regulatory Affairs (DRA). Introduction to Drug Regulatory Affairs. Why Drug Regulatory Affairs?. Role of Regulatory Affairs Experts. Types of the company hiring RA professionals. RA professional can get employment. Regulatory Bodies.
“A GMP is a system for ensuring that products are consistently produced and controlled according to quality standards. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product”.
The India Pharmaceutical Industry is developing, producing and marketing drugs.
The pharmaceutical companies are generally dealing in generic or brand medications and medical device.
Indian Pharmaceutical Industry today is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology.
India enjoys a important position in the global pharmaceutical market. The Indian pharmaceuticals market is the third largest in terms of volume and thirteenth largest in terms of value.
It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured.
complete description about pharmaceutical industry how it work how it is operated both at micro as well as macro level. it also include leading pharma firms in market. in simple words if we say it is an industry analysis.
Regulatory affairs in Pharmaceutical IndustryRama Shukla
Regulatory affairs is a profession developed from the desire of governments to protect public health by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines.
Good Manufacturing Practice (GMP) is a system for ensuring that products are consistently produced and controlled according to quality standards. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product.
Pharmaceutical, Bulk Drugs and Medicine Manufacturing Industry (Production, F...Ajjay Kumar Gupta
Quality control and quality assurance are vital in this industry. Many production workers are assigned full time to quality control and quality assurance functions, whereas other employees may devote part of their time to these functions. For example, although pharmaceutical company sales representatives, often called detailers, work primarily in marketing, they engage in quality control when they assist pharmacists in checking for outdated products.
Advances in manufacturing processes are also impacting the industry. While pharmaceutical manufacturers have long devoted resources to new drug development as a source for future profits, firms are increasingly realizing that improvements throughout the drug pipeline are needed to stay competitive.
See more
http://goo.gl/1sQLwS
http://goo.gl/jajeNa
http://goo.gl/0tvlst
http://www.entrepreneurindia.co/
Tags
Pharmaceutical Technology Books, Essentials of Pharmaceutical Technology, Pharmaceutical Technology, Pharmaceutical books, Science, Technology & Medicine Books, Drugs technology books, Drug and Pharmaceuticals technology book, Best small and cottage scale industries, Bulk Drugs Formulation, Bulk Drugs Manufacturing Industry, Business consultancy, Business consultant, Business guidance for Pharmaceutical industry, Business guidance to clients, Business Plan for a Startup Business, Creating a Pharma Start-up, Drug formulation manual, Formulation of Antibiotics, Formulation of Paracetamol, Formulation of Tablets, Great Opportunity for Startup, How to Start a Medicines manufacturing business?, How to start a pharmaceutical company, How to Start a Pharmaceutical Product Business, How to Start a Pharmaceutical Production Business, How to start a pharmacy business, How to start a successful drugs making business, How to start Antibiotics manufacturing business, How to start drugs pharmaceutical business, How to start medicine business, How to Start Medicine Manufacturing Industry in India, How to start medicine manufacturing, How to start Paracetamol production business, How to Start Pharmaceutical Manufacturing Company in India, Invest to setup a pharmaceutical business, Manufacturing of medicinal products- Pharmaceutical industry, Medicine Manufacturing Industry, Medicines Making Small Business Manufacturing, Modern small and cottage scale industries, Most Profitable Bulk Drugs production Business Ideas, New small scale ideas in Pharmaceutical industry, Pharma Manufacturing, Pharmaceutical and Medicines production Business, Pharmaceutical Based Profitable Projects, Pharmaceutical Based Small Scale Industries Projects, Pharmaceutical Drug Formulation, Pharmaceutical Drug Manufacturing Business, Pharmaceutical formulation guidelines, Pharmaceutical formulation, Pharmaceutical industry in India, Pharmaceutical industry, Pharmaceutical manufacturing Industry in India, Pharmaceutical Manufacturing Industry, Pharmaceutical Projects,
Quality control measures in pharmaceutical industryChemOnTheGo
QUALITY CONTROL
ROLE OF QUALITY CONTROL IN PHARMACEUTICAL INDUSTRY
OBJECTIVES OF QUALITY CONTROL
STEPS IN QUALITY CONTROL
COST OF QUALITY CONTROL
TOTAL QUALITY MANAGEMENT
QUALITY CIRCLE
Regulatory authorities (US-FDA, WHO and ICH)Sagar Savale
To promote the public health by promptly and efficiently reviewing clinical research and taking appropriate action on the marketing of regulated products in a timely manner.
With respect to such products, protect the public health by ensuring that the food are safe, Wholesome, sanitary, and properly labelled; human and veterinary drugs are safe and effective; there is reasonable assurance of the safety and effectiveness of devices intended for human use; cosmetics are safe and properly labelled, and public health and safety are protected from the electronic product radiation.
Participates through appropriate process with representatives of other countries to reduce the burden of regulation, harmonize regulatory requirements, and achieve appropriate reciprocal arrangements.
DRA (Drug Regulatory Affairs) , RA (Regulatory Affairs)Naman Ruhela
A Brief Introduction about the Regulatory Affairs / Drug Regulatory Affairs (DRA). Introduction to Drug Regulatory Affairs. Why Drug Regulatory Affairs?. Role of Regulatory Affairs Experts. Types of the company hiring RA professionals. RA professional can get employment. Regulatory Bodies.
REGULATORY LABELING AND THE INDUSTRY CHALLENGESFreyr Solutions
To comply with time-critical labeling mandates, organizations face many procedural challenges while creating, tracking and managing various aspects of drug labeling lifecycle.
In that regard, before even searching for a right labeling solution.....
USFDA Approval Process For Drug Products & Biological Product i.e NDA Vs. BLA
Comparison of NDA and BLA application process in USA. IND, NDA, ANDA & BLA dossier submission procedure.
Pilot Plant Scale Up Techniques Used in Pharmaceutical Manufacturing, Prof. Dr. Basavaraj K. Nanjwade, KLE University College of Pharmacy, Belgaum/Belagavi
In-plant Training Report at Ziska Pharmaceuticals Ltd. by~ WaliullahWaliullah Wali
ZISKA PHARMACEUTICAL LTD.
In Plant Training
Training Period: From August 06, 2014 to August 19, 2014Duration: 14 Days
Training Areas:
WarehouseProduction DepartmentQuality Assurance & Quality Control Department Product Development DepartmentMaintenance & Engineering Department
Introduction
In Bangladesh the pharmaceutical sector is one of the most developed hi-tech sectors within the country's economy.
This sector is also providing 97% of the total medicine requirement of the local market.
Recently few new industries have been established with high tech equipment’s and professionals which will enhance the strength of this sector.
Ziska Pharmaceutical Ltd. is one of them.
PROFILE ABOUT ZISKA PHARMACEUTICAL LTD.
Company Name: Ziska Pharmaceutical Ltd.
Factory Location: Karol Surichala, Safipur, Gazipur
Head Office: Nurul tower, 34- Purana Paltan line, Dhaka-1000
Corporate Setup: Private Limited Company.
Manufacturing areas: 146500 sft.
Established Year: 1986
Popular Products OF ZISKA PHARMACEUTICAL LTD.
Engineering department
Engineering department
The Engineering department deals with the complete maintenance of the production and companies total working environment .
The Engineering section of Ziska Pharmaceuticals Ltd. covers the following Utilities :
Production machineries.
Electricity supply
Air Handling
Water supply
Emergency supply
Repairing, restoring and reporting
Worker distribution and pest control.
Engineering department
Utility Service
Electricity:
Required electricity mainly obtained from DESA, incase of load shedding heavy duty generator provide electricity.
Generator:
Name: Cummins
Type: diesel operated.
Capacity: 1750 kilowatt.
Requirement: 1500 kilowatt.
Engineering department
Engineering department
HVAC:
It means Heating Ventilation Air Conditioning (HVAC). It maintains optimum temperature and humidity throughout the factory.
All seeks to provide thermal comfort , acceptable indoor air quality and reasonable installation operation.
Engineering department
HVAC:
Controlling of temperature and Relative Humidity in deferent areas-
Dispensing: 22±2°C 45±5% RH
Solid &Liquid: 22±2°C 55±5% RH
Sterile: 22±2°C 50±5% RH
Low humidity requiring rooms: 22±2°C 25±5% RH
Minimum air change rate:
Class B 30/hr
Class C 30/hr
Class D not less than 15/hr
Engineering department
HVAC system:
Engineering department
HVAC system:
Engineering department
Chiller system:
This system is involved for the production of chilled water which is supplied through the pipe to produce air conditioning system.
Process:
Engineering department
Engineering department
HEPA Filter
High-efficiency particulate air Filter or HEPA filter is an air filter that must remove (from the air that passes through) 99.97% of 0.3 µm size particles.
Smaller and larger particles are filtered at even greater efficiency.
The effi
Drug Regulatory Affairs By Mr. Pankaj DhapadePankaj Dhapade
This presentation covers basic understandings of regulatory affairs profession. It contains,
1. Introduction of Regulatory Affairs
2. Why Drug Regulatory Affairs
3. Role of Regulatory Affairs Experts
4. Qualities of Regulatory Affairs Expert
5. Qualities for Submission Management
6. Regulatory Bodies
This document gives detailed information regarding the processes followed in a Pharma Manufacturing Company.
It also includes graphical representation, for easy understanding.
Regulations for drug approval in USA, E.U & India
Pharmaceutical industry is the most regulated of all the industries. Regulations are put in order to develop the most efficient and safe pharmaceutical products. It takes more than 8 to 15 years to develop a new drug product & costs more than $ 800 million.
Webinar validation of pharmaceutical manufacturing processesDr. Ganesh Prasad
This is a one hour presentation on the recent concepts of pharmaceutical manufacturing process validation in line with the 2011 FDA and EMA guidelines.
Quality by Design (QbD) is a systematic approach to pharmaceutical development that begins with predefined objectives and emphasizes product and process understanding and process control, based on sound science and quality risk management.
DEFINITION,PRINCIPLE, OBJECTIVES, ELEMENTS AND TOOLS OF QUALITY BY DESIGN (Qb...Durgadevi Ganesan
Quality by Design is a concept first outlined by Joseph M. Juran in various publications. He supposed that quality could be planned. The concept of QBD was mention in ICH Q8 guidelines, which states that, “To identify quality can not be tested in products, i.e. Quality should be built in to product by design.”
What is Quality by Design (QbD)?
Quality by Design (QbD) is a strategic approach employed in various industries, including pharmaceuticals, manufacturing, and product development, to ensure the consistent delivery of high-quality products.
Why QbD?
Principle of QbD
Objectives of QbD
ELEMENTS OF PHARMACEUTICAL QUALITY BY DESIGN:
- Quality Target Product Profile
- Critical Quality Attributes
- Product Design and Understanding
- Process Design and Understanding
- Process Design and Understanding
- Design space
- Control Strategy
- Continual Improvement
DESIGN TOOLS
- Prior Knowledge
- Risk Assessment
- Mechanistic Model, Design of Experiments, and Data Analysis
- Process Analytical Technology
Quality management systems - INDUSTRIAL PHARMACY llJafarali Masi
syllabus
Quality management & Certifications: Concept of Quality, Total Quality Management, Quality by Design (QbD), Six Sigma concept, Out of Specifications (OOS), Change control, Introduction to ISO 9000 series of quality systems standards, ISO 14000, NABL, GLP
Pharmaceutical Good Manufacturing PracticesPharmaceutical
When you are in healthcare, Then GMP is must. Regulatory philosophy for product Quality have been changed from "Quality by Testing QbT" to "Quality by Design QbD". Quality is to be built in product and that only can be done by GMP.
Quality Management System including the Quality management and certificationAshwiniRaikar1
Concept of Quality, Total Quality Management, Quality by Design, Six Sigma concept, Out of Specification, Change control, Introduction to ISO 9000 Series of quality system standards, ISO 14000,NABL, GLP
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
2. Outline
Describe the Functions and Responsibilities
performed by various departments within
pharmaceutical industry.
(If any difference found that will depend on focus, size, history, risk
tolerance, available resources and expertise in pharmaceutical
companies)
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
3. Pharma Industry
Production / Mfg.
House
Clinical Research
Organization
(CRO)
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
5. Three key personnel are named on a
pharmaceutical manufacturing site’s
Manufacturing Licence.
1. Head of Production
2. Head of Quality Control
3. Qualified Person (s) – (QP)
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
7. Head of Production
• Products produced and stored according to appropriate documentation.
• Approval of production instructions and their strict implementation.
• Ensure production records are evaluated prior to sending to QC.
• Maintenance of department, premises and equipment.
• Validations performed.
• Initial and on-going training.
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
8. Quality Control
Chemical QC Microbiological QC Packaging QC
• API Testing QC
• FP Testing QC
• Instrument QC
• Microbial Testing QC
• E.M QC
• Pkg.Material Testing
• Art work Check
• Pack Insert Check
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
9. Head of Quality Control
• Approve or reject materials
(All components, Drug product containers, Closures, In-process
materials, Packaging material, Labelling and Drug Products.)
• Evaluate batch records.
• Ensure all testing performed.
• Approve specifications, etc.
• Ensure that if errors have occurred, that they have been fully
investigated
• Approve and monitor contract analysis.
• Maintain department, premises and equipment.
• Validations performed.
• Initial and on-going training.
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
10. Shared duties of
Heads of Production and QC
• Authorisation of written procedures and other documents.
• Monitoring and control of the manufacturing environment.
• Plant hygiene.
• Process validation.
• Training.
• Approval and monitoring of suppliers.
• Approval and monitoring of contract manufacture.
• Designation and monitoring of storage conditions.
• Retention of records.
• Monitoring of compliance to GMP.
• Inspection, investigation and taking samples.
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
11. The Qualified Person [QP]
(EU GMP)
• Products manufactured within EU – a QP must ensure that each batch
was produced and tested according to GMP and Licensed conditions
• Products manufactured outside the EU – a QP must ensure that each
imported batch has undergone, in the importing country re-testing and
evaluation
• A QP must sign a register to state that the above has been performed
satisfactorily before product is released (QP certification)
• Product Quality Review performed in a timely manner and accurate
(EU GMP 1.5)
• QP have authority to certify a batch for release.
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
12. Quality Assurance
System QA
• Vendor Audit
• Internal Audit
• Change Control
• CAPA
• Complaint handling
• Training
Process QA
• IPQA
• Risk Assessment
• Deviation
• OOS / OOT
• Process Validation
• Equipment Validation
• Software Validation
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
13. Role of QA
The role of QA is not defined in GMP and as per
EU roles already assigned in GMP to the Head
of QC and the QP can be delegated to QA, with
additional roles added as well.
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
14. Role of QA
• Control of Licences
• Liaison with Research & Development/ New Product Introduction
• Batch Review
• Batch Release
• Management of the Document Management system
• Management of the Internal Audit system
• Management of the GMP Training System
• Customer feedback and satisfaction
• Management of deviations, incidents and investigations
• Management of the Validation system
• Vendor assurance and supplier auditing
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
15. Role of QA
• Control of sub-contractors
• Performance monitoring and review
• Management Review
• Management of the Continual Improvement system
• Gathering and Trending of quality related data
• Data storage
• Management of the Product Quality review process
• Management of the Risk Management process
• Management of the Corrective Action system
• Management of the Preventative Action system
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
18. Role of the Engineering
• In the manufacture of medicines the equipment used and the
environment it is located in has a massive impact on product quality.
• The role of the Engineering Manager is therefore critical.
• Some of the roles already assigned in GMP to the Head of
Production can be delegated to Head of Engineering
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
19. Role of Head of Engineering
• Maintenance of premises and equipment.
• Design of facilities.
• Validation and qualification of equipment and facilities.
• Management of the calibration programme.
• Management of the Planned Preventative Maintenance
programme.
• Control and operation of site services (including water, steam
and HVAC systems).
• Control of engineering spares/ equipment spares.
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
20. Role of Head of Engineering
• Control of engineering contactors.
• Approval of engineering related procedures, documents and
drawings.
• Control and storage of engineering records.
• Control of equipment manuals.
• Pest control.
• Site security and access.
• Project Management.
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
21. Quality Management System
Pharmaceutical Quality Management Systems
(PQMS)
FDA
“Guidance for Quality Systems”
ICH Q10
“Guidance on Pharmaceutical Quality Systems”.
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
22. ICH Q10 model
ICH Q10 describes one comprehensive model
for an effective pharmaceutical quality system, It
can be implemented throughout the different
stages of a product lifecycle
• International Organization for Standardization (ISO) quality
concepts
• Good manufacturing practice (GMP) regulations
• ICH “Q8 Pharmaceutical Development”
• ICH “Q9 Quality Risk Management
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
23. QMS enhance the Quality and Availability of
medicines
It always facilitate Innovation and Continual
improvement and strengthen the link between
Pharmaceutical development and Manufacturing
activities.
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
24. Product Lifecycle Technical Activities
Pharmaceutical Development
– Drug substance development
– Formulation development (including container/closure system)
– Manufacture of investigational products
– Delivery system development (where relevant)
– Manufacturing process development and scale-up
– Analytical method development
Technology Transfer
– New product transfers during development through manufacturing
– Transfers within or between manufacturing and testing sites for marketed products
Commercial Manufacturing
– Acquisition and control of materials
– Provision of facilities, utilities, and equipment
– Production (including packaging and labeling)
– Quality control and assurance
– Release
– Storage
– Distribution
Product Discontinuation
– Retention of documentation
– Sample retention
– Continued product assessment and reporting
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
25. ICH Q10 Objectives
• Achieve Product Realization :
To establish, implement, and maintain a system that allows the delivery of
products with the quality attributes (e.g RA compliance & Reg.authority for
approval of regulatory filings)
• Establish and Maintain a State of Control:
To develop and use effective monitoring and control systems for process performance
and product quality (e.g Quality risk management)
• Facilitate Continual Improvement :
To identify and implement appropriate product quality improvements, process
improvements, variability reduction, innovations, and pharmaceutical quality system
enhancements (e.g Quality risk management)
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
26. Quality Risk Management
(ICH Q9)
Quality Risk Management is integral to an
effective pharmaceutical quality system.
It can provide a Proactive Approach to
– Identifying
– Scientifically Evaluating &
– Controlling Potential Risks to quality.
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
27. MANAGEMENT RESPONSIBILITY
• Management Commitment :
– Senior management - Ensure an effective quality objectives
• Quality Policy :
– Quality policy that describes the overall intentions and direction of the company related to
quality
– An expectation to comply with applicable regulatory requirements, continual improvement
– Policy should be reviewed periodically for continuing effectiveness
• Quality Planning :
– Quality objectives should align with the company’s strategies and be consistent with the
quality policy
– Management should provide the appropriate resources and training
• Resource Management :
• Internal Communication :
• Management Review :
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
28. Corrective And Preventive Action
(CAPA)
In general, CAPA experts recommend that root cause
investigations follow a four-step process:
• Identify the problem.
• Evaluate its magnitude, which includes assessing risk.
• Investigate and assign responsibility.
• Analyze and document the root cause of the problem.
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
29. Quality Assurance
All of the Quality Assurance’s audits are based on the
Pharmaceutical Law
Good Manufacturing Practice (GMP)
&
Good Laboratory Practice (GLP) Guidelines.
Good Quality Assurance System leads to a constant
increase of reliability and ensures compliance with
the currant regulatory requirements.
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
30. Regulatory Affairs
Regulated Market
(US, EU, MCC etc.)
Semi-Regulated Market /
Rest of World (RoW)
Market
• DMF
• CTD / eCTD
• NDA / ANDA
• DMF (Open Part / Close Part)
• Registration Dossier
• Tech. Pack
Pharma Product
Biological / Biotech
Product
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
31. Regulatory Affairs Department
Responsible for managing the interface between
the Sponsor and Regulatory Agencies (eg, FDA)
so that the information gained through the R&D
process meets the criteria for product
registration.
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
32. Functions in Regulatory Affairs
• Submission to Regulatory Authorities
• Participates in supporting and promoting electronic submissions and
electronic archives.
• Ensures that regulatory documents comply with the relevant guidelines.
• Identifies and records issues that require resolution prior to finalization
and liaises with responsible author to resolve issues.
• Assists authors in the completion and compilation of regulatory
documents to ensure all components are provided and presented in the
correct format.
• May provide training to functional group contributors on regulatory
document content and format.
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
34. Major Components of the Clinical
Department
Statistician
Outcomes
Research
Clinician
Data
Services
Medical
Writer
Clinical
Research
Associate
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
35. Functions in Clinical Operations
– Project Management.
– Managing and coordination of study conduct
– Monitoring and tracking of project milestones to ensure that the
project runs within timelines.
– Participation as appropriate to CORE TEAMS to expedite the
feasibility and conduct of global trials
– Ensuring that the regulatory and EC’s submission are of
acceptable quality
– Support Investigator as and when required (e.g. Finalisation of
Investigator agreements and contracts; Finalisation of Protocols)
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
36. Functions in Pharmacovigilance
• Collect, follow-up, transmit all local adverse events (AEs), and pregnancy
cases, to Global Pharmacovigilance.
• Process cases in accordance with Global and Local Pharmacovigilance
procedures.
• Answer queries and requests from Global Pharmacovigilance.
• Answer ADR and ADR case processing questions from local Regulatory
Authorities and Health Care Professionals.
• Submit the reportable ADRs, (local & foreign) to the local Regulatory
Authorities according to the national regulations.
• Developing and maintaining the local Pharmacovigilance SOPs and Work
Practice Documents.
• Provide input into labeling changes to the Regulatory Affairs Department.
• To identify all local safety observational studies (Post-Authorization Safety
Studies), in conjunction with Regulatory Affairs.
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
37. Global Regulatory Guidelines
• ISO Guidelines (International Organization for Standardization)
• WHO Guidelines (World Health Organization)
• US-FDA Guidelines (United State Food & Drug Administration)
• ICH Guidelines (International conference on Harmonization)
• PIC/S Guidelines (Pharm. Inspection Convention & Pharm. Inspection
Co-operation Scheme)
• IPEQ Guidelines (International Pharmaceutical Excipients Council)
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
38. Global Regulatory Agencies
• UK - MHRA (Medicines & Healthcare Products Reg. Agency)
• South Africa - MCC (Medicine Control Conceal)
• Australia - TGA (Therapeutic Goods Administration)
• India - Drug & Cosmetic Act / Schedule M
• EU – EDQM (European Directorate for the Quality of Medicines &
HealthCare)
• Newzeland - MEDSAFE
• Gulf - GCC
• Japan - PDMA (Pharmaceutical & Medical devices Agency)
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
39. WHAT NEXT
Build your knowledge and experience level to
match the desired attributes.
• Attend Seminars or Courses in Regulatory,
QA/QC, GMP, Clinical trial design, Statistics etc.
• Acquire Specialized disease knowledge
• Acquire Specialized formulation knowledge
Publish (something - - - anything!)
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)
40. What to do
[Knowledge, Skills and Abilities]
• Industry Knowledge/ Experience: Knowledge of applicable FDA regulatory
standards and requirements.
• Communication Skills: Advanced level of written and verbal communication
skills with the ability to read, analyze and interpret general business
periodicals, professional journals, technical procedures or governmental
regulations. Ability to write reports, business correspondence and
procedure manuals. Ability to effectively present information to plant
employees and the general public and lead in a team environment.
• Reasoning Ability: Ability to solve practical problems and deal with a
variety of concrete variables in situations where only limited standardization
exists. Ability to interpret a variety of instructions furnished in written, oral,
diagram or schedule form.
• Leadership: Effectively manage competing priorities, adaptable to
change, demonstrated ability to accept additional responsibilities and manage
tasks through teamwork.
Girish A. Swami (M.Pharm, PGDIPR, PGDDRA)